[en] AIM: The aim of this study is to determine the prevalence and evolution of anaemia in prospectively followed children and adolescents diagnosed with Crohn's disease (CD). METHODS: The BELCRO registry (inclusion May 2008-April 2010), describing current clinical treatment practice of children diagnosed with CD, provided data on age, height, body mass index (BMI), paediatric Crohn's disease activity index (PCDAI), therapy and haemoglobin (Hb) at diagnosis 12 and 24 months follow-up. Anaemia was defined as Hb < -2 sd, while severe anaemia was defined as Hb < -4 sd. Patients were classified as child </=13 and adolescent >13 years of age. RESULT: Ninety-six were included, 13 dropped out due to insufficient Hb data (37 females/46 males; median age 13.3 years, range 2.2-17.8 years). At diagnosis, the median Hb sd was -2.66 (-8.4; 1.07) and was correlated with the PCDAI (p = 0.013). At diagnosis, 51/83 (61 %) were anaemic and all had active disease. Hb z-score significantly improved (p < 0.0001) but 26/68 (38 %) remained anaemic at 12 months and 29/76 (38 %) at 24 months of follow-up. The correlation to the PCDAI disappeared. At 24 months, children were more likely to be anaemic. There was no difference in iron dose nor duration of iron supplements between children and adolescents. Iron treatment was more readily given to patients presenting with anaemia. Hb did not differ between patients with (n = 28) or without iron supplements. Half of the patients with persisting anaemia were given iron supplements, of which, only three were given intravenously. CONCLUSION: Anaemia remains an important extra-intestinal manifestation of CD in children. Physicians, lacking optimal treatment strategies, undertreat their patients.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Van Biervliet, Stephanie
Smets, Francoise
Hofmann, Ilse
Degreef, Elisabeth
Hauser, Bruno
Bontems, Patrick
Vande Velde, Saskia
Arts, Wim
Paquot, Isabelle
Alliet, Philippe
Bossuyt, Peter
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Pels LPM, Van de Vijver E, Waalkens HJ, Uitentuis J, Gonera-de Jong G, van Overbeek LAT, Norbruis OF, Rings EHHM, van Rheenen PF (2010) Slow hematological recovery in children with IBD-associated anemia in cases of "expectant management". J Pediatr Gastroenterol Nutr 51: 708-713.
Wiskin AE, Fleming BJ, Wootton SA, Beattie RM (2012) Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohn's Colitis 6: 687-691.
Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM, Lindsay JO, Sanderson IR, Rampton DS (2012) Prevalence and management of anemia in children, adolescents and adultswith inflammatory bowel disease. InflammBowel Dis 18: 513-519.
Wells CW, Lewis S, Barton JR, Corbett S (2006) Effects of changes in haemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 12: 123-130.
Wilson A, Reyes E, Ofman J (2004) Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of literature. Am J Med 116: 44S-49S.
Thayu M, Mamula P (2005) Treatment of iron deficiency anemia in inflammatory bowel disease. Curr Treat Options Gastroenterol 8: 411-417.
Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schroeder O, Stein J, Travis S, Van Assche G (2007) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 13: 1545-1553.
De Greef E, Mahachie John JM, Hoffman I, Smets F, Van Biervliet S, ScaillonM, Hauser B, Paquot I, Alliet P, ArtsW, Dewit O, Peeters H, Baert F, D'Haens G, Rahier JF, Etienne I, Bauraind O, Van Gossum A, Vermeire S, Fontaine F, Muls V, Louis E, Van de Mierop F, Coche JC, Van Steen K, Veereman G, for the IBD working group of the Belgian Society of Pediatric Gastroenterology, Hepatology and Nutrition (BeSPGHAN), and the Belgian IBD Research and Development (BIRD) (2013) Profile of pediatric Crohn's disease in Belgium. J Crohn's Colitis. doi: 10. 1016/j. crohns. 2013. 04. 016.
Otley A, Loonen H, Parekh N, Corey M, Sherman PM, Griffiths AM (1999) Assessing activity of pediatric Crohn's disease: which index to use? Gastroenterology 116: 527-531.
Nathan DG, Orkin SH, Lock AT, Ginsburg D (2003) Nathan and Oski's hematology of infancy and childhood. Saunders, Philadelphia.
Kulnigg S, Gasche C (2006) Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 24: 1507-1523.
de Silva AD, Tsironi E, Feakins RM, Rapmton DS (2005) Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 22: 10977-105.
Lee TW, KolberMR, Fedorak RN, Veldhuyzen van Zanten S (2012) Iron replacement therapy in inflammatory bowel disease patients with Iron deficiency anemia: a systematic review and meta-analysis. J Crohn's Colitis 6: 267-275.
Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN (2002) Total dose intravenous infusion of iron dextran for iron deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 34: 286-290.
Gisbert JP, Bermejo F, Pajares R, Pérez-Calle JL, Rodríguez M, Algaba A, Mancenido N, de la Morena F, Carneros JA, McNicholl AG, González-Lama Y, Maté J (2009) Oral and intravenous iron treatment in inflammatory bowel disease: haematological response and quality of life improvement. Inflamm Bowel Dis 15: 1485-1491.
